Racial/Ethnic Differences in Concerns About Current and Future Medications Among Patients With Type 2 Diabetes

Details

• Alternative Title:
  Diabetes Care
• Personal Author:
  Huang, Elbert S. ; Brown, Sydney E.S. ; Thakur, Nidhi ; Carlisle, Lisabeth ; Foley, Edward ; Ewigman, Bernard ; Meltzer, David O.
• Description:
  To evaluate ethnic differences in medication concerns (e.g., side effects and costs) that may contribute to ethnic differences in the adoption of and adherence to type 2 diabetes treatments.|We conducted face-to-face interviews from May 2004 to May 2006 with type 2 diabetic patients > or =18 years of age (N = 676; 25% Latino, 34% non-Hispanic Caucasian, and 41% non-Hispanic African American) attending Chicago-area clinics. Primary outcomes of interest were concerns regarding medications and willingness to take additional medications.|Latinos and African Americans had higher A1C levels than Caucasians (7.69 and 7.54% vs. 7.18%, respectively; P < 0.01). Latinos and African Americans were more likely than Caucasians to worry about drug side effects (66 and 49% vs. 39%, respectively) and medication dependency (65 and 52% vs. 39%, respectively; both P < 0.01). Ethnic minorities were also more likely to report reluctance to adding medications to their regimen (Latino 12%, African American 18%, and Caucasian 7%; P < 0.01). In analyses adjusted for demographics, income, education, and diabetes duration, current report of pain/discomfort with pills (odds ratio 2.43 [95% CI 1.39-4.27]), concern regarding disruption of daily routine (1.97 [1.14-3.42]), and African American ethnicity (2.48 [1.32-4.69]) emerged as major predictors of expressed reluctance to adding medications.|Latinos and African Americans had significantly more concerns regarding the quality-of-life effects of diabetes-related medications than Caucasians. Whether these medication concerns contribute significantly to differences in treatment adoption and disparities in care deserves further exploration.
• Subjects:
  Adult Attitude To Health Black People Diabetes Mellitus, Type 2 Drug Therapy Hemoglobin A, Glycosylated Hispanic Or Latino Humans Hypoglycemic Agents Interviews As Topic Patient Compliance Predictive Value Of Tests Quality Of Life White People Young Adult

  More +
• Source:
  Diabetes Care. 32(2):311-316.
• Document Type:
  Journal Article
• Funding:
  K23 AG021963/AG/NIA NIH HHS/United States ; K23 AG021963-04/AG/NIA NIH HHS/United States ; K23-AG021963/AG/NIA NIH HHS/United States ; P30-CD000147/CD/ODCDC CDC HHS/United States ; P60 DK20595/DK/NIDDK NIH HHS/United States ; U36-CCU319276/PHS HHS/United States
• Place as Subject:
  Chicago, IL
• Volume:
  32
• Issue:
  2
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:860665f65754c80214f5bc0ad0bae8bd9abbc6efc48a56b6b574ff16bc7f619a
• Download URL:
  https://stacks.cdc.gov/view/cdc/22925/cdc_22925_DS1.pdf
• File Type:
  [PDF - 82.24 KB ]